Abiopharma

GENTEX CORP (GNTX)

Symbol	GNTX
Name	GENTEX CORP
Sector	CONSUMER DISCRETIONARY
Region	North America
Industry	Motor Vehicle Parts & Accessories
Address	600 N CENTENNIAL ST, ZEELAND, MI 49464
Telephone	6167721800
Fax	—
Email	—
Website	https://www.gentex.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000355811
Description	Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue, and the company is constantly developing new applications for the technology to remain on top. Sales in 2021 totaled about $1.7 billion with 41.8 million mirrors shipped. The unit mix breaks out as 65% interior and 35% exterior, versus about 32% exterior in 2020. The company is based in Zeeland, Michigan. Additional info from NASDAQ: Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue, and the company is constantly developing new applications for the technology to remain on top. Sales in 2021 totaled about $1.7 billion with 41.8 million mirrors shipped. The unit mix breaks out as 65% interior and 35% exterior, versus about 32% exterior in 2020. The company is based in Zeeland, Michigan.

2026-05-05 19:53

BROWN LESLIE L 🟡 adjusted position in 17.2K shares (2 derivative) of GENTEX CORP (GNTX) at $22.85 Transaction Date: May 05, 2026 | Filing ID: 000002

2026-04-30 20:08

📋 RICHARD SCHAUM (Director) plans to sell 5K shares of GENTEX CORPORATION (at $23.31 each, total $112K) Filed: Apr 30, 2026 | ID: 003849

2026-04-30 18:14

Schaum Richard O 🟡 adjusted position in 9.2K shares (1 derivative) of GENTEX CORP (GNTX) at $23.31 Transaction Date: Apr 30, 2026 | Filing ID: 000002

2026-04-29 19:53

New Form SCHEDULE 13G - GENTEX CORP Filed: 2026-04-29 AccNo: 0002100119-26-000571 Size: 7 KB

2026-04-24 12:00

(30% Negative) GENTEX CORP (GNTX) Reports Q2 2026 Financial Results

2026-04-24 12:00

Gentex Reports First Quarter 2026 Financial Results

2026-04-09 12:00

Gentex Corporation Recognizes Boyd as Supplier of the Year for the Second Consecutive Year

2026-04-09 09:02

New Form DEFA14A - GENTEX CORP Filed: 2026-04-09 AccNo: 0000355811-26-000017 Size: 3 MB

2026-04-09 09:01

New Form DEF 14A - GENTEX CORP Filed: 2026-04-09 AccNo: 0000355811-26-000016 Size: 6 MB

2026-03-26 19:37

New Form SCHEDULE 13G/A - GENTEX CORP Filed: 2026-03-26 AccNo: 0000102909-26-001332 Size: 7 KB